Evidence map›Paper›PMID 40927152›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Improving Brain Tumor Treatment through Nanotechnology and Proton Therapy Using Laser-driven Accelerators through GEANT4 Simulation.

Mehdi Kavehnia, Hossein Sadeghi, Seyede Nasrin Hosseinimotlagh

Abstract read
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mehdi KavehniaDepartment of Physics, Faculty of Sciences, Arak University, Arak, Iran.
Hossein SadeghiDepartment of Physics, Faculty of Sciences, Arak University, Arak, Iran.
Seyede Nasrin HosseinimotlaghDepartment of Physics, Shi.C., Islamic Azad University, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Another approach to improve the dose conformity is to use charged particles like protons instead of the conventional X- and γ-rays. Protons exhibit a specific depth-dose distribution which allows to achieve a more targeted dose deposition and a significant sparing of healthy tissue behind the tumor. In particular, proton therapy has, therefore, become a routinely prescribed treatment for tumors located close to sensitive structures. Moreover, the track structure and energy transfer of protons is different from those of photons which can provide advantages in terms of biological effectiveness. Furthermore, the application of nanotechnology in radiotherapy also offers interesting approaches to improve the therapeutic index. Methods: Therefore, in this work, we first introduce the water phantom and simultaneously inject high-energy protons into it through a pencil beam and 50 nm nanoparticles (NPs) with different concentrations and investigate the increase in the absorbed dose. Then, we present a more realistic model of brain tumor and study the increase in the absorbed dose in the activated tumor in two cases with and without the injection of gold, silver, and platinum NPs into the brain phantom. The simulation software used in this article is GEANT4. Results: As can be seen from this work, the absorbed dose with the injection of NPs at an energy of 150 MeV is, in order, from highest to lowest, related to platinum, gold, silver, and finally water without the injection of NPs, and this is due to the fact that the number of secondary electrons produced by platinum is more than gold, gold is more than silver and silver is more than water (Pt>Au>Ag>W). Conclusion: This work shows that the optimum energy deposited in the Bragg curve at the end of the brain tumor is 110 MeV.

Indexed as

Braindosenanoparticlesphantomtreatmenttumor

Identifiers

PMID40927152
PMCPMC12416606

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.